The invention concerns a novel MMP-27 transmembrane matrix metalloproteinase which is expressed in tumour cells. The invention concerns a method for screening compounds capable of affecting the activity of MMP-27, and the use of said compounds for making a medicine for the treatment of cancer, in particular for preventing and/or inhibiting the formation of metastases, vascularization of tumours and for treating inflammatory diseases.
展开▼
